These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

712 related items for PubMed ID: 12734778

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Interaction of the growth hormone receptor with cytokine-induced Src homology domain 2 protein in rat adipocytes.
    Du L, Frick GP, Tai LR, Yoshimura A, Goodman HM.
    Endocrinology; 2003 Mar; 144(3):868-76. PubMed ID: 12586763
    [Abstract] [Full Text] [Related]

  • 4. Endotoxin-induced inhibition of growth hormone receptor signaling in rat liver in vivo.
    Mao Y, Ling PR, Fitzgibbons TP, McCowen KC, Frick GP, Bistrian BR, Smith RJ.
    Endocrinology; 1999 Dec; 140(12):5505-15. PubMed ID: 10579313
    [Abstract] [Full Text] [Related]

  • 5. Role of the cytokine-inducible SH2 protein CIS in desensitization of STAT5b signaling by continuous growth hormone.
    Ram PA, Waxman DJ.
    J Biol Chem; 2000 Dec 15; 275(50):39487-96. PubMed ID: 10991939
    [Abstract] [Full Text] [Related]

  • 6. Endoplasmic reticulum stress prolongs GH-induced Janus kinase (JAK2)/signal transducer and activator of transcription (STAT5) signaling pathway.
    Flores-Morales A, Fernández L, Rico-Bautista E, Umana A, Negrín C, Zhang JG, Norstedt G.
    Mol Endocrinol; 2001 Sep 15; 15(9):1471-83. PubMed ID: 11518796
    [Abstract] [Full Text] [Related]

  • 7. Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton.
    Rico-Bautista E, Negrín-Martínez C, Novoa-Mogollón J, Fernández-Perez L, Flores-Morales A.
    Exp Cell Res; 2004 Mar 10; 294(1):269-80. PubMed ID: 14980520
    [Abstract] [Full Text] [Related]

  • 8. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
    Liang L, Zhou T, Jiang J, Pierce JH, Gustafson TA, Frank SJ.
    Endocrinology; 1999 May 10; 140(5):1972-83. PubMed ID: 10218944
    [Abstract] [Full Text] [Related]

  • 9. Dual mechanism of signal transducer and activator of transcription 5 activation by the insulin receptor.
    Le MN, Kohanski RA, Wang LH, Sadowski HB.
    Mol Endocrinol; 2002 Dec 10; 16(12):2764-79. PubMed ID: 12456798
    [Abstract] [Full Text] [Related]

  • 10. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins.
    Hansen JA, Lindberg K, Hilton DJ, Nielsen JH, Billestrup N.
    Mol Endocrinol; 1999 Nov 10; 13(11):1832-43. PubMed ID: 10551777
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor.
    Dif F, Saunier E, Demeneix B, Kelly PA, Edery M.
    Endocrinology; 2001 Dec 10; 142(12):5286-93. PubMed ID: 11713228
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3.
    Denson LA, Held MA, Menon RK, Frank SJ, Parlow AF, Arnold DL.
    Am J Physiol Gastrointest Liver Physiol; 2003 Apr 10; 284(4):G646-54. PubMed ID: 12519742
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Modulation and lack of cross-talk between signal transducer and activator of transcription 5 and Suppressor of cytokine signaling-3 in insulin and growth hormone signaling in 3T3-L1 adipocytes.
    Story DJ, Stephens JM.
    Obesity (Silver Spring); 2006 Aug 10; 14(8):1303-11. PubMed ID: 16988072
    [Abstract] [Full Text] [Related]

  • 16. SOCS-1, -2, -3: selective targets and functions downstream of the prolactin receptor.
    Tomic S, Chughtai N, Ali S.
    Mol Cell Endocrinol; 1999 Dec 20; 158(1-2):45-54. PubMed ID: 10630404
    [Abstract] [Full Text] [Related]

  • 17. Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms.
    Ueki K, Kondo T, Kahn CR.
    Mol Cell Biol; 2004 Jun 20; 24(12):5434-46. PubMed ID: 15169905
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo.
    Chow JC, Ling PR, Qu Z, Laviola L, Ciccarone A, Bistrian BR, Smith RJ.
    Endocrinology; 1996 Jul 20; 137(7):2880-6. PubMed ID: 8770909
    [Abstract] [Full Text] [Related]

  • 19. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.
    Cousin SP, Hügl SR, Myers MG, White MF, Reifel-Miller A, Rhodes CJ.
    Biochem J; 1999 Dec 15; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851
    [Abstract] [Full Text] [Related]

  • 20. Insulin resistance-inducing cytokines differentially regulate SOCS mRNA expression via growth factor- and Jak/Stat-signaling pathways in 3T3-L1 adipocytes.
    Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, Klein J, Paschke R.
    J Endocrinol; 2004 Apr 15; 181(1):129-38. PubMed ID: 15072573
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.